ZyVersa Therapeutics, Inc. (ZVSA) NASDAQ

0.19

+0(+0.00%)

Updated at July 31 03:53PM

Currency In USD

Valuation

Market Cap1.18M
Enterprise Value-354,289
P/E Ratio-0
PEG Ratio-0
Price/Sales Ratio0
Price/Book Ratio0
Enterprise/Revenue0
Enterprise/EBITDA0.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.22
Return On Equity-1.12

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-9.14B
Net Income-9.41B
Diluted EPS-8.48

Balance Sheet

Total Cash1.61M
Total Cash/Share518.69
Total Debt0
Total Debt/Equity0
Current Ratio0.18
Book Value Per Share2,616.85

Price History

52-Week Change-94.51
52-Week High3.96
52-Week Low0.12
Moving Average 50 Days0.54
Moving Average 200 Days1.01

Statistics

Average Volume5.56M
Shares Outstanding7.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateApril 26, 2024